Institution of Biotechnology, Maria Biotech Co., 102-9 Sinsuldong, Seoul, 130-812, Korea.
Cytotechnology. 2015 Oct;67(5):851-60. doi: 10.1007/s10616-014-9725-0. Epub 2014 Jul 6.
Although stem cells are promising candidates for cell replacement therapies, the vast majority are derived using animal sera, which has risk of being contaminated by animal viruses or toxins. To overcome these potential problems, we initially established multiple lines of stem cells from first-trimester human placenta (fPMSC), which were cultivated using human follicular fluid (hFF) instead of fetal bovine serum (FBS). FF provides a very important microenvironment for the development of oocytes. No differences were found in the general morphology, growth rate, karyotype, gene and surface expressions between placental MSCs cultured in 5 % hFF-supplemented medium (fPMSC-X) or 10 % FBS-supplemented medium (fPMSC). Differentiation experiments confirmed similar levels of potency in cells grown in either condition. Since hFF preserved the unique features of the stem cells and is free from potential pathogens, it should be considered as the main culture medium supplement for the propagation of human stem cells for clinical applications.
虽然干细胞是细胞替代疗法的有前途的候选者,但绝大多数是使用动物血清衍生的,这存在被动物病毒或毒素污染的风险。为了克服这些潜在的问题,我们最初从人胎盘(fPMSC)建立了多个干细胞系,这些干细胞系使用人卵泡液(hFF)而不是胎牛血清(FBS)培养。FF 为卵母细胞的发育提供了非常重要的微环境。在 5% hFF 补充培养基(fPMSC-X)或 10% FBS 补充培养基中培养的胎盘 MSC 的一般形态、生长速度、核型、基因和表面表达没有差异。分化实验证实,在这两种条件下生长的细胞具有相似的潜能水平。由于 hFF 保留了干细胞的独特特征,并且没有潜在的病原体,因此它应该被视为用于临床应用的人干细胞繁殖的主要培养基补充物。